Ixekizumab
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1397 publications
Real-World Efficacy and Safety of Ixekizumab in the Treatment of Psoriasis: A Case-Series from Indian Sub-Continent.
Journal: Indian journal of dermatology
Published: September 08, 2026
Practical Saudi Guidelines on management of moderate-to-severe psoriasis: 2026 update.
Journal: The Journal of dermatological treatment
Published: September 07, 2026
Anti-IL-17 therapy in people living with HIV who have cutaneous psoriasis: A four-patient case series.
Journal: International journal of STD & AIDS
Published: September 03, 2026
Effectiveness of brodalumab in biologic-experienced adults with moderate to severe plaque psoriasis: a focused narrative review.
Journal: The Journal of dermatological treatment
Published: August 12, 2026
IL-17 at the eye-joint interface in psoriatic disease: mechanisms, clinical correlates, and therapeutic implications.
Journal: Expert review of clinical immunology
Published: August 10, 2026
Speed of Response in Biologic Treatments for Moderate-to-Severe Plaque Psoriasis: Bayesian Network Meta-Analysis.
Journal: Journal of drugs in dermatology : JDD
Published: August 05, 2026
Beyond the Usual Targets: A Case Report of Overcoming IL-23 and IL-17A Biologic Nonresponse in Palmoplantar Psoriasis With Brodalumab.
Journal: The Journal of clinical and aesthetic dermatology
Published: July 22, 2026
Clinical characteristics, treatment and prognosis of ixekizumab-induced inflammatory bowel disease.
Journal: Immunopharmacology and immunotoxicology
Published: July 09, 2026
Biologic therapies in pediatric psoriasis: A single-center experience.
Journal: Archivos argentinos de pediatria
Published: June 30, 2026
Successful treatment of recalcitrant Hailey-Hailey disease with ixekizumab.
Journal: JAAD case reports
Published: June 12, 2026
IL-17 ligand-targeting inhibitors in psoriatic arthritis: a focused systematic review and network meta-analysis of efficacy, safety, and certainty of evidence.
Journal: Frontiers in immunology
Published: May 27, 2026
Ixekizumab With or Without Tirzepatide in Adults With Psoriasis and Overweight or Obesity: A Phase 3b Randomized Clinical Trial.
Journal: JAMA dermatology
Published: May 15, 2026
Last Updated: 09/26/2026